New Diagnostic Criteria for Mild Traumatic Brain Injury: Medical-Legal Considerations

Disclosures: Grant Iverson, Ph.D. serves or has served as a scientific advisor for NanoDX®, Sway Operations, LLC, and Highmark, Inc. He has a clinical and consulting practice in forensic neuropsychology, including expert testimony, involving individuals who have sustained mild TBIs. He has received past research support or funding from several test publishing companies, including ImPACT Applications, Inc., CNS Vital Signs, and Psychological Assessment Resources (PAR, Inc.). He receives royalties from the sales of one neuropsychological test 3 (WCST-64). He has received research funding as a principal investigator from the National Football League, and subcontract grant funding as a collaborator from the Harvard Integrated Program to Protect and Improve the Health of National Football League Players Association Members. He acknowledges unrestricted philanthropic support from the Mooney-Reed Charitable Foundation, ImPACT Applications, Inc., National Rugby League, the Heinz Family Foundation, Boston Bolts, and the Schoen Adams Research Institute at Spaulding Rehabilitation. None of the above entities were involved in the study design, analysis, interpretation, the writing of this article, or the decision to submit it for publication. Kristen Dams-O'Connor, Ph.D. has provided expert testimony, consultation, and independent examinations involving cases pertaining to brain injury. William J. Panenka, M.D. reports academic grants unrelated to this work, including funds from the Canadian Institute of Health Research, the Vancouver General Hospital Foundation, and British Columbia Ministry of Health. Jaclyn A. Stephens, Ph.D., OTR/L has received research funding as a principal investigator from the National Institutes of Health (NIH), serves as a Chair of a Data Safety Monitoring Board for an NIH R01 study focused on sports-related concussion, and is a Co-Chair of the Athlete Development Sports Rehabilitation Task Force of the American Congress of Rehabilitation Medicine. None of the above entities were involved in the study design, analysis, interpretation, the writing of this article, or the decision to submit it for publication. Steven D. Lockman, M.D. has received payment for expert testimony. Zainab Al Lawati, M.D., M.Ed., FRCPC, FAAPMR has no disclosures. Anthony H. Lequerica, Ph.D. reports a grant from the New Jersey Commission on Brain Injury Research and expert testimony fees. Jacob I. McPherson, DPT, Ph.D. has no disclosures. Joshua Kamins, M.D. serves as a consultant for Lundbeck Pharmaceuticals and he has also been a member of their speakers bureau. He is a clinical neurologist and has provided expert testimony on legal cases involving mild TBIs. Noah D. Silverberg, Ph.D. reports grants from the Canadian Institutes of Health Research, Canadian Foundation for Innovation, VGH+UBC Hospital Foundation, and WorkSafeBC, and clinical consulting fees from the National Hockey League and Major League Soccer, and expert testimony fees.